Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type, Application & End-User The global lithotripsy devices market will witness a robust CAGR of 5.5%, valued at $1.65 billion in 2021, expected to appreciate and reach $2.68 billion by 2030, confirms Strategic Market Research. Lithotripsy is a medical procedure used to treat kidney stones that can cause urinary tract infections and stones in organs like the liver or gallbladder. It utilizes sound waves to disintegrate large kidney stones into smaller pieces and can be easily observed through fluoroscopy. Ultrasonic waves break the stone into smaller pieces that can pass through the urinary system and works by giving shock waves to the stone in the desired site. These shock waves are generated by a lithotripter machine and are focused by the x-ray onto the kidney stone. These waves travel into the body through the skin & tissue, and after finally reaching the stone, they break it down into small fragments. As per the National kidney foundation, 1 in 3 adults with diabetes and 1 in 5 adults with high BP may have kidney disease. According to a recent study by The George Washington University, 2022, in the United States, Washington, D.C is the leading state for Chronic kidney disease; about 1 in 3 American adults are at risk of kidney disease, while 26 million American adults already suffer from CKD. An increase in the prevalence of urolithiasis, a rise in the number of extracorporeal shock waves lithotripsy procedures, and advancements in technology are the primary drivers of the market. Major Drivers - Increase in the Prevalence of Urolithiasis, a Rise in the Number of Extracorporeal Shock Waves Lithotripsy Procedures, and Advancements in Technology Upsurge in the geriatric population across the globe is the significant factor responsible for driving the growth of the lithotripsy devices market. As per the National Institutes of Health (NIH), 617 million, that means 8.5% out of the total population globally is aged 65 and above; also, it is expected that this percentage will reach 17% in the year 2050, which means around 1.6 billion people will be aged 65 and over in 2050. Furthermore, the report released by the UN Population Fund and HelpAge India suggests that the number of aged population is expected to be 173 million by 2026. Increasing investments in the development of advanced technology and the factors such as favorable government policies regarding diagnostic testing like urine microscopy tests and X-rays also strengthen the market's overall growth. According to a recent study furnished by the University of Washington School of Medicine in Seattle, in nine out of 23 stones, complete fragmentation with ≤2 mm occurred within 10 minutes of the burst wave lithotripsy procedure. Increased prevalence of Urolithiasis, a common urologic problem, and a significant global burden on the healthcare system with a risk of end-stage renal failure are the key factors driving the demand for lithotripsy devices. As per the European Association of Urology report, the prevalence rates for urinary stones varied from 1% to 20%. The countries which have a high standard of living, such as Canada, Sweden, or the U.S, renal stone prevalence is more than 10%. For some areas increase of more than 37% has been reported over the last 20 years. Restraints - Adverse Risks with Lithotripsy Treatment Several risks are highly associated with the lithotripsy treatment. It can sometimes lead to internal bleeding and may need a blood transfusion. It can also have side effects like kidney damage which can be occurred due to the blockage in the urine flow passage caused by tiny stone particles associated with complications, such as high blood pressure. Opportunities - Focus on Government Policies, Investments, and Innovations The government is focusing on the research and development of the global lithotripsy devices market with huge investments and initiating policies in developing economies that can create ample opportunities for the market's overall growth in the upcoming years. As per the National Library of Medicine, high-income countries spend around 2-3% of their annual health care budget on treating kidney diseases. The emerging countries should also focus on budget planning for the market's growth in the upcoming years. The rising product launches like Extracorporeal Lithotripter, Intracorporeal Lithotripter, and pneumatic lithotripters, the commercialization of these products and technologies in many countries are projected to increase, creating ample opportunities in the future. Market Analysis Of Different Segments Covered in the Report Based on Type Extracorporeal Shock Wave Lithotripsy Devices Intracorporeal Lithotripsy Devices Laser Lithotripsy Devices Electrohydraulic Lithotripsy Devices Ultrasonic Lithotripsy Devices Mechanical Lithotripsy Devices Based on Applications Kidney Stones Ureteral Stones Pancreatic Stones Bile Duct Stones Based on End-User Hospitals Ambulatory Surgical Centres Other End Users Regional Coverage Analysis North America United States Canada Mexico Europe France Germany U.K Spain Italy Rest of Europe Asia Pacific China India South Korea Japan Australia Rest of APAC The Middle East and Africa GCC South Africa Rest of the Middle East and Africa South America Brazil Argentina Rest of South America Segments Analysis & Insights Based on Type, the Extracorporeal Shock Wave Lithotripsy Devices (ESWL) segment dominated the market in 2020. It is a technique for treating stones in the kidney and ureter that does not require any kind of surgery. Adopting these non-invasive devices assists in terms of quicker treatments and offers advantages like reduced pain, shorter hospital stay, and quick recovery time. These are the key factors leading to the market’s overall growth. Based on Applications, the kidney stones segment dominated the overall industry with a steady CAGR during the estimated period. As per the National Kidney Foundation, approximately 90% of the population, or 2 out of 5 adults, are unaware that they have kidney disease. This is due to the increase in the occurrence of kidney stones, thereby propelling this segment's overall growth. Based on End Users, the Hospitals segment dominated the overall market with a steady CAGR during the estimated period. Since the recovery time has improved with the help of advanced surgical methods, most surgical procedures are performed in hospitals. This is the primary reason driving this segment's overall growth. Based on Regions, North America accounted for the largest industry share in 2020. As per CDC, in 2020, around 37 million people, i.e., 1 out of every 7, or 15% of the adult population, were estimated to have chronic kidney diseases. The highest percentage of the North American region can primarily be attributed to the increase in stone formations causing urolithiasis and the increased risk of renal disease among the population. As per the US Department of Health and Human Services 2021, end-stage renal disease (ESRD) is a significant public health problem in the US and a major source of suffering. Lithotripsy Devices Market Report Coverage Report Attribute Details Forecast Period 2021-2030 Market size value in 2021 USD 1.65 Billion Revenue forecast in 2030 USD 2.68 Billion Growth rate 5.5% Base year for estimation 2021 Historical data 2017 - 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Technology, By End User, and By Region. By Type Intracorporeal Lithotripsy Device & Extracorporeal Shock Wave Lithotripsy Device By Application Kidney Stones, Ureteral Stones, Pancreatic Stones and Bile Duct Stones By End-User Hospitals and Ambulatory Surgical Centres By Region North America, Europe, Asia Pacific and LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles Dornier MedTech, Allengers, Technomed Medical Systems, ELMED™ USA Medical Systems, SODY Medical Equipment Co. Ltd., NOVAMEDTEK, Siemens Medical Solutions USA, Inc., Olympus Corporation, Shockwave Medical Inc., EDAP TMS, STORZ Medical AG, Lumenis, Direx Group, Medispec Ltd. , Boston Scientific Corporation, Beijing SODY Medical Equipment Co. Ltd., Apex-MediTech Lithotripsy Devices Market Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors prevailing in the market environment. The comparison is performed based on implementing specific strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help the companies to strengthen their industry positions and focus on increasing lithotripsy devices' applications to support positions over the forecasted period. Dornier MedTech Allengers Technomed Medical Systems ELMED™ USA Medical Systems SODY Medical Equipment Co. Ltd. NOVAMEDTEK Siemens Medical Solutions USA, Inc. Olympus Corporation Shockwave Medical Inc. EDAP TMS STORZ Medical AG Lumenis Direx Group Medispec Ltd. Boston Scientific Corporation Beijing SODY Medical Equipment Co. Ltd. Apex-MediTech Recent Developments On February 2021, Shockwave Medical Inc., which is a leader in the development of Intravascular Lithotripsy (IVL) to cure severely calcified cardiovascular diseases, declared that the company’s sonic pressure wave therapy had gained Pre-Market Approval for severely calcified coronary artery disease from the U.S. FDA (Food and Drug Administration). After this approval, IVL will now be commercially available in the U.S. to cure problematic calcium in the coronary arteries. In March 2021, Dornier MedTech GmbH became the world's first integrated urology company to be certified by the European Union's Medical Device Regulation (MDR) for its Class IIb products: Dornier Delta III, one of the most potent lithotripters that utilizes Dornier's Extracorporeal Shock Wave Lithotripsy (ESWL), mobile Lithotripsy technology; and the Dornier UIMS, a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones. In March 2021, Boston Scientific acquired Lumenis in a $1.07 billion deal to strengthen its product portfolio for the market, which will add to the industry's growth. In February 2021, Shockwave received clearance from the US Food and Drug Administration for treating severely calcified coronary artery plaques, which uses a balloon to deliver sonic pressure waves that can pass through soft arterial tissue to “preferentially disrupt” calcified plaque and optimize stent placement. Frequently Asked Question About This Report Which segment is lithotripsys Largest Market share in an application? The kidney stone segment dominated the overall market in 2020 due to the increase in kidney stones, propelling this segments overall growth. What are the key Lithotripsy Devices Market trends? Increase in the prevalence of urolithiasis, a rise in the number of extracorporeal shock waves lithotripsy procedures, and advancements in technology and rising awareness. What are the instruments used in lithotripsy? Extracorporeal Shock Wave Lithotripsy and Intracorporeal Lithotripsy are the instruments used in lithotripsy. Is lithotripsy still used, and how much is lithotripsy? It is available at many hospitals, outpatient centres, and sometimes even in mobile units, with an average cost of $12,800, ranging from $7,250 to $16,450. Which are three different types of lithotripsies? Ultrasonic lithotripsy, Electrohydraulic lithotripsy (EHL), and Extracorporeal shock wave lithotripsy (ESWL) are three different lithotripsies. What are electromagnetic lithotripsy and endoscopic lithotripsy? Electromagnetic lithotripsy seems to have a more acute harmful renal effect and causes high numbers of RBC in patients with renal stones. Endoscopic lithotripsy is a visualization of a calculus in the urinary tract and the simultaneous application of energy to fragment the stones into either extractable or passable pieces. How big will the Lithotripsy Devices Market be? The Lithotripsy Devices Market size was USD 1.65 billion in 2021 and is predicted to reach USD 2.68 billion by 2030 with a CAGR of 5.5% from 2021 to 2030. Sources https://www.kidney.org/news/newsroom/fsindex https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease https://www.washington.edu/urology/2020/02/13/uw-researchers-use-burst-wave-lithotripsy-to-successfully-treat-kidney-stones-in-first-10-humans/ https://uroweb.org/guidelines/urolithiasis/chapter/guidelines 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size By bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size By Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Lithotripsy Devices Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, By region, 2021 - 2030 (USD Million) 4.4 By Type Business Analysis 4.4.1 Market, By Type, 2021 - 2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2021) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Extracorporeal Shock Wave 7.3.1. Extracorporeal Shock Wave Market, 2021 - 2030 (USD Million) 7.4. Intracorporeal 7.4.1. Intracorporeal Market, 2021 - 2030 (USD Million) 7.5. Laser 7.5.1. Laser Market, 2021 - 2030 (USD Million) 7.6. Electrohydraulic 7.6.1. Electrohydraulic Market, 2021 - 2030 (USD Million) 7.7. Ultrasonic 7.7.1. Ultrasonic Market, 2021 - 2030 (USD Million) 7.8. Mechanical 7.8.1. Mechanical Market, 2021 - 2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals Market, 2021 - 2030 (USD Million) 8.4. Ambulatory Surgical Centers 8.4.1. Ambulatory Surgical Centers Market, 2021 - 2030 (USD Million) 8.5. Other End Users 8.5.1. Other End Users Market, 2021 - 2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Kidney Stones 9.3.1. Kidney Stones Market, 2021 - 2030 (USD Million) 9.4. Ureteral Stones 9.4.1. Ureteral Stones Market, 2021 - 2030 (USD Million) 9.5. Pancreatic Stones 9.5.1. Pancreatic Stones Market, 2021 - 2030 (USD Million) 9.6. Bile Duct Stones 9.6.1. Bile Duct Stones Market, 2021 - 2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Type, 2021 - 2030 (USD Million) 10.1.2. North America Market, By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, By Application, 2021 - 2030 (USD Million) 10.1.4. North America Market, By Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Type, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, By Application, 2021 - 2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada Market, By Type, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, By Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Type, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, By Application, 2021 - 2030 (USD Million) 10.2.4. Europe Market, By country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Type, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, By Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Type, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, By Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Type, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, By Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Type, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, By Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Type, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, By Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, By country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Type, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, By Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Type, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, By Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Type, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, By Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Type, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, By Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Type, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, By Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Type, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, By Application, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, By country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Type, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, By Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Type, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, By Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America Market, By Type, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, By Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Type, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, By Application, 2021 - 2030 (USD Million) 10.5.4. MEA Market, By Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Dornier MedTech 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. ALLENGERS 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. TECHNOMED MEDICAL SYSTEMS 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. ELMED™ USA MEDICAL SYSTEMS 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. SODY MEDICAL EQUIPMENT CO. LTD 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. NOVAMEDTEK 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Siemens Medical Solutions USA, Inc 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Olympus Corporation. 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Shockwave Medical Inc 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. EDAP TMS 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. STORZ Medical AG 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Lumenis. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Direx Group 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Medispec Ltd 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. Boston Scientific Corporation 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. Beijing SODY Medical Equipment Co. Ltd 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.17. Apex-MediTech 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development List of Tables (71 Tables) TABLE 1. MARKET, By Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Extracorporeal Shock Wave , BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Intracorporeal , BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Laser , BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Electrohydraulic , BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Ultrasonic , BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Mechanical , BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET, By End-User, 2021-2030 (USD Million) TABLE 9. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Ambulatory Surgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Other End Users, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Food & Beverages, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Kidney Stones, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Ureteral Stones, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Pancreatic Stones, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Bile Duct Stones, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Battery Powered , BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, By Type, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 38. Dornier MedTech: COMPANY SNAPSHOT TABLE 39. Dornier MedTech: OPERATING SEGMENTS TABLE 40. ALLENGERS: COMPANY SNAPSHOT TABLE 41. ALLENGERS: OPERATING SEGMENTS TABLE 42. TECHNOMED MEDICAL SYSTEMS: COMPANY SNAPSHOT TABLE 43. TECHNOMED MEDICAL SYSTEMS: OPERATING SEGMENTS TABLE 44. ELMED™ USA MEDICAL SYSTEMS : COMPANY SNAPSHOT TABLE 45. ELMED™ USA MEDICAL SYSTEMS : OPERATING SEGMENTS TABLE 46. SODY MEDICAL EQUIPMENT CO. LTD: COMPANY SNAPSHOT TABLE 47. SODY MEDICAL EQUIPMENT CO. LTD: OPERATING SEGMENTS TABLE 48. NOVAMEDTEK: COMPANY SNAPSHOT TABLE 49. NOVAMEDTEK: OPERATING SEGMENTS TABLE 50. Siemens Medical Solutions USA, Inc: COMPANY SNAPSHOT TABLE 51. Siemens Medical Solutions USA, Inc: OPERATING SEGMENTS TABLE 52. Olympus Corporation: COMPANY SNAPSHOT TABLE 53. Olympus Corporation: OPERATING SEGMENTS TABLE 54. Shockwave Medical Inc: COMPANY SNAPSHOT TABLE 55. Shockwave Medical Inc: OPERATING SEGMENTS TABLE 56. EDAP TMS: COMPANY SNAPSHOT TABLE 57. EDAP TMS: OPERATING SEGMENTS TABLE 58. STORZ Medical AG: COMPANY SNAPSHOT TABLE 59. STORZ Medical AG: OPERATING SEGMENTS TABLE 60. Lumenis: COMPANY SNAPSHOT TABLE 61. Lumenis: OPERATING SEGMENTS TABLE 62. Direx Group: COMPANY SNAPSHOT TABLE 63. Direx Group: OPERATING SEGMENTS TABLE 64. Medispec Ltd: COMPANY SNAPSHOT TABLE 65. Medispec Ltd: OPERATING SEGMENTS TABLE 66. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 67. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 68. Beijing SODY Medical Equipment Co. Ltd: COMPANY SNAPSHOT TABLE 69. Beijing SODY Medical Equipment Co. Ltd: OPERATING SEGMENTS TABLE 70. Apex-MediTech: COMPANY SNAPSHOT TABLE 71. Apex-MediTech: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 17 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for , By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Extracorporeal Shock Wave (ESWL) to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 16 Kidney Stone to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview